Vanthys Pharmaceutical Development Private Limited

Vanthys Pharmaceutical Development Private Limited - pharma in Noida, Uttar Pradesh, India. Directors, charges & compliance details.
CIN U73100UP2009PTC037333 Incorporated 11 May 2009 ROC Kanpur HQ Noida, Uttar Pradesh, India
Dissolved (Liquidated) Private Limited Company pharma
Revenue · FY 2018
₹29.46 Lakh
▲ 0.03% YoY
Net profit · FY 2018
₹20.55 Lakh
Net margin 69.8%
EBITDA · FY 2018
₹27.56 Lakh
EBITDA margin 93.6%
Authorised capital
₹22.5 Cr
Registered with MCA
Paid-up capital
₹22.5 Cr
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
4
As per MCA filings
Key managerial staff
1
CEO, CFO, company secretary

About Vanthys Pharmaceutical Development Private Limited

Data last updated:

Vanthys Pharmaceutical Development Private Limited was a private limited company based in Noida, Uttar Pradesh, India, operated as a subsidiary of Jubilant Innovation Pte. Limited. The company has been dissolved (liquidated) as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 11 May 2009.

The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U73100UP2009PTC037333. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹22.5 Cr and a paid-up capital of ₹22.5 Cr. It was led by directors including Benny Thomas and Shyamsundar Bang.

Its last annual general meeting (AGM) was held on 20 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301.

As per the financials filed for FY 2018, the company reported a revenue of ₹29.46 Lakh. For the same year it recorded a net profit of ₹20.55 Lakh (net margin 69.8%) and EBITDA of ₹27.56 Lakh (EBITDA margin 93.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.

The company was associated with 4 brands: Jubilant Biosys, Jubilant Pharma, Jubilant Pharmova and Jubilant Life Sciences. The company has 1 deal on record (1 acquisition); the latest was in January 2012. Its 10 peer companies in the Pharma industry (Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Orcivita Sciences and Research Private Limited with revenue of ₹31.4 Lakh.

The last known website on record is jubilantpharmova.com.

Company details

CIN U73100UP2009PTC037333
Registration Number 037333
Incorporation Date 11 May 2009
ROC Kanpur
Listing Status Unlisted
Company Status Dissolved (Liquidated)
Parent Company Jubilant Innovation Pte. Limited
Compliance Status Active Compliant

Contact details

Vanthys Pharmaceutical Development Private Limited's registered office is in Noida, Uttar Pradesh. Its website is jubilantpharmova.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Vanthys Pharmaceutical Development Private Limited, buy the company report.

Comprehensive company report
Vanthys Pharmaceutical Development Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Vanthys Pharmaceutical Development operates multiple associated brands including Jubilant Biosys, Jubilant Pharma, and Jubilant Pharmova. Each brand links to its own profile.

BrandDescriptionWebsite
Offers integrated drug discovery, research, and manufacturing for pharmaceuticals.jubilantbiosys.com
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.jubilantpharma.com
CDMO focused on manufacturing of solid, semi solid, liquid, and injectible drug formulationsjubilantpharmova.com
Company offering a suite of R&D and manufacturing services for small molecules and genericsjubl.com

Financials of Vanthys Pharmaceutical Development Private Limited

FY 2018 filings available

Vanthys Pharmaceutical Development Private Limited reported revenue of ₹29.46 Lakh for FY 2018.

Revenue · FY 2018
₹29.46 Lakh
Net profit · FY 2018
₹20.55 Lakh margin 69.8%
EBITDA · FY 2018
₹27.56 Lakh margin 93.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 1%

Revenue has grown at a compounded annual rate (CAGR) of 1% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹29.46 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹27.56 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹20.55 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin93.6%
Net Profit Margin69.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Vanthys Pharmaceutical Development Private Limited, buy the company report.

Board of directors and KMP of Vanthys Pharmaceutical Development Private Limited

Vanthys Pharmaceutical Development Private Limited currently reports 3 directors and 1 key managerial person. 18 former directors have served the organization.

Directors and KMP (as last reported)
NameDesignationAppointment DateTenureStatus
Benny ThomasDirector28 Mar 20188 Years 7 MonthsAs last reported
Saravanakumar DhakshinamoorthyAdditional Director15 May 20197 Years 6 MonthsAs last reported
Shwetank TiwariCompany Secretary16 Jan 20188 Years 10 MonthsAs last reported
Shyamsundar BangDirector28 Mar 20188 Years 7 MonthsAs last reported

Peer comparison

Vanthys Pharmaceutical Development Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Orcivita Sciences and Research Private Limited₹31.4 Lakh (FY 2024)83.0%Kolkata, West Bengal, India
Clinfound Diagnostics Private Limited₹30.82 Lakh (FY 2025)-73.0%Thodupuzha, Kerala, India
Smo Clinical Research (India) Private Limited₹30.36 Lakh (FY 2025)-72.0%Bangalore, Karnataka, India
P.T Healthcare Private Limited₹30.24 Lakh (FY 2025)Nadia, West Bengal, India
Suncure Pharmaceutical Private Limited₹30.11 Lakh (FY 2023)-49.0%Bangalore, Karnataka, India
Vanthys Pharmaceutical Development Private Limitedthis company₹29.46 Lakh (FY 2018)₹20.55 Lakh69.8%Noida, Uttar Pradesh, India
Omicsgen Lifesciences Private Limited₹29.32 Lakh (FY 2024)-25.0%Kanayannur, Kerala, India
Ethitrials Contract Research Private Limited₹29.27 Lakh (FY 2024)20.0%Ahmedabad, Gujarat, India
Chemengg Research Private Limited₹29.07 Lakh (FY 2024)-13.0%Pune, Maharashtra, India
Nkure Therapeutics Private Limited₹28.47 Lakh (FY 2025)87.0%Bangalore, Karnataka, India
Solvitall Research Labs Private Limited₹28.07 Lakh (FY 2024)Chengalpattu, Tamil Nadu, India

To see the full peer comparison of Vanthys Pharmaceutical Development Private Limited, buy the company report.

Auditor

Vanthys Pharmaceutical Development Private Limited is audited by B S R & Co. LLP for the financial year 2018.

Auditor firmFinancial yearFirm registration number
B S R & Co. LLPFY 2018101248W/W100022

Shareholding

The shareholding of Vanthys Pharmaceutical Development Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Vanthys Pharmaceutical Development Private Limited, buy the company report.

Deals & funding

Vanthys Pharmaceutical Development Private Limited has 1 deal on record (1 acquisition); the latest was in January 2012.

Total deals
1
Acquisition
1

Deals on record (1 of 1)

WhenDealAmountParties
Jan 2012AcquisitionUndisclosedBuyer: Jubilant Pharmova Limited
Seller: Eli Lilly and Co.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Vanthys Pharmaceutical Development Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Vanthys Pharmaceutical Development has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Vanthys Pharmaceutical Development Private Limited, buy the company report.

Recent activity

Vanthys Pharmaceutical Development Private Limited has 20 board changes on record since 2011: 4 appointments and 16 cessations. The latest: Shyamsundar Bang ceased to be Director on 03 Feb 2021.

Ceased
Shyamsundar Bang ceased to be Director.
Ceased
Ashutosh Agarwal ceased to be Managing Director.
Appointed
Saravanakumar Dhakshinamoorthy was appointed as Additional Director.
AGM
Vanthys Pharmaceutical Development Private Limited last Annual general meeting of members was held on 20 Sep 2018 as per latest MCA records.
Ceased
Benny Thomas ceased to be Additional Director.
Filing
Vanthys Pharmaceutical Development Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Kanpur.
Appointed
Benny Thomas was appointed as Director.
Ceased
Sanjay Das ceased to be Director.
Ceased
Sankaraiah Rajagopal ceased to be Director.
Ceased
Shyam Nath Singh ceased to be Director.
Appointed
Shyamsundar Bang was appointed as Director.
Ceased
Prakash Chandra Bisht ceased to be Director.

11 earlier events are in the company report.

Frequently asked questions

Vanthys Pharmaceutical Development has been "Dissolved (Liquidated)" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.

Vanthys Pharmaceutical Development was a private limited company based in Noida, Uttar Pradesh, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 11 May 2009 and is registered under CIN U73100UP2009PTC037333. The company is recorded as dissolved (liquidated) in MCA records and no longer exists as a legal entity.

Vanthys Pharmaceutical Development was incorporated on 11 May 2009. It is registered with the Registrar of Companies, Kanpur.

Vanthys Pharmaceutical Development had 4 directors and KMP:

The CIN (Corporate Identification Number) of Vanthys Pharmaceutical Development is U73100UP2009PTC037333. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Vanthys Pharmaceutical Development is at 1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301.

Vanthys Pharmaceutical Development can be reached through the website jubilantpharmova.com. Its registered office is in Noida, Uttar Pradesh, India.

The latest financial statements of Vanthys Pharmaceutical Development on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 20 September 2018. Year-wise statements from 2015 are in the company report.

No. Vanthys Pharmaceutical Development has 1 GST registration on record and it is cancelled or inactive.

Vanthys Pharmaceutical Development operated in the pharma industry, in the pharma contract r and d segment.

Vanthys Pharmaceutical Development has 1 deal on record (1 acquisition); the latest was in January 2012.